Drug intelligence / Profile preview

Danggui Tiaojing Granules

Development stage: Unknown
Lead developer: Zhejiang Dongfang Pharmaceutical
Administration: Oral

Overview

Danggui Tiaojing Granules is a traditional Chinese medicine (TCM) formulation developed and marketed by Sichuan Defeit Pharmaceutical. Administered orally as granules, it is primarily used in gynecological health for regulating menstrual cycles, alleviating menstrual pain, and improving blood circulation. The formulation is based on Danggui (*Angelica sinensis*), a key herb in TCM known for its blood-tonifying and blood-moving properties. As a TCM product, it functions through a multi-component, multi-target mechanism consistent with traditional medical theory rather than a single defined molecular target. It is an approved and marketed product in China.

Brand names: Danggui Tiaojing Granules
Other names: 当归调经颗粒Danggui Tiaojing Kele

Beyond the preview

Go deeper on Danggui Tiaojing Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Danggui Tiaojing Granules.

Explore the full profile